Erratum

Split Viewer

J Rheum Dis 2025; 32(1): 68-68

Published online January 1, 2025

© Korean College of Rheumatology

Erratum: Implication of serious infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis for the first cycle of rituximab: a pilot study in a single Korean center

Hyunsue Do, M.D.1, Jung Yoon Pyo, M.D.1,2, Jason Jungsik Song, M.D., Ph.D.1,2, Yong-Beom Park, M.D., Ph.D.1,2, Sang-Won Lee, M.D., Ph.D.1,2

1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 2Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea

Correspondence to : Sang-Won Lee, https://orcid.org/0000-0002-8038-3341
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. E-mail: sangwonlee@yuhs.ac

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

J Rheum Dis 2023;30(1):45-52

https://doi.org/10.4078/jrd.22.0033

We discovered that a missing word in the Figure 1 and would like to correct it.

The corrected version should be as follows:

Before:

Patients with AAV receiving rituximab and having serious infection (n=33)

After:

Patients with AAV receiving rituximab and having no serious infection (n=33)

We sincerely apologize for any confusion that we may have caused.

Article

Erratum

J Rheum Dis 2025; 32(1): 68-68

Published online January 1, 2025 https://doi.org/10.4078/jrd.22.0033E

Copyright © Korean College of Rheumatology.

Erratum: Implication of serious infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis for the first cycle of rituximab: a pilot study in a single Korean center

Hyunsue Do, M.D.1, Jung Yoon Pyo, M.D.1,2, Jason Jungsik Song, M.D., Ph.D.1,2, Yong-Beom Park, M.D., Ph.D.1,2, Sang-Won Lee, M.D., Ph.D.1,2

1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 2Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea

Correspondence to:Sang-Won Lee, https://orcid.org/0000-0002-8038-3341
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. E-mail: sangwonlee@yuhs.ac

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Body

J Rheum Dis 2023;30(1):45-52

https://doi.org/10.4078/jrd.22.0033

We discovered that a missing word in the Figure 1 and would like to correct it.

The corrected version should be as follows:

Before:

Patients with AAV receiving rituximab and having serious infection (n=33)

After:

Patients with AAV receiving rituximab and having no serious infection (n=33)

We sincerely apologize for any confusion that we may have caused.

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download